Why the study?
What are the clinical experience, pharmacokinetic characteristics, and suggested guidelines for the use of amiodarone in pediatric patients?
What are the clinical experience, pharmacokinetic characteristics, and suggested guidelines for the use of amiodarone in pediatric patients?
This paper reviews the clinical experience and pharmacokinetics of amiodarone in children and suggests guidelines for its use.
Supports cautious amiodarone use in children per suggested guidelines; leaves open prospective validation.
The reported world clinical experience of amiodarone in children is revieived; the known age‐dependent electro physiological and pharmacokinetic characteristics of amiodarone are examined; and guidelines for the use of amiodarone in children are suggested.
No takes yet. Share an insight, caveat, or question.
Dick et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: